Search

Author/Creator Liao, Ran

3. E48 Effects of baricitinib on haematological laboratory parameters in patients with rheumatoid arthritis. (25th April 2018)

Authors:
Huizinga, Thomas W; Kay, Jonathan; Harigai, Masayoshi; Keystone, Edward; Smolen, Josef; Rosas, José; Emery, Paul; Hall, Stephen; van den Bosch, Filip; Schienberg, Morton; Dudler, Jean; Liao, Ran; Meszaros, Gabriella; Barry, Jane; Kremer, Joel
Journal:
Rheumatology
Issue:
Volume 57(2018)Supplement 3
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial. Issue 12 (December 2021)

Authors:
Marconi, Vincent C; Ramanan, Athimalaipet V; de Bono, Stephanie; Kartman, Cynthia E; Krishnan, Venkatesh; Liao, Ran; Piruzeli, Maria Lucia B; Goldman, Jason D; Alatorre-Alexander, Jorge; de Cassia Pellegrini, Rita; Estrada, Vicente; Som, Mousumi; Cardoso, Anabela; Chakladar, Sujatro; Crowe, Brend...
Journal:
Lancet
Issue:
Volume 9:Issue 12(2021)
Page Start:
1407
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Efficacy and safety of baricitinib in combination with topical corticosteroids in patients with moderate‐to‐severe atopic dermatitis with inadequate response, intolerance or contraindication to ciclosporin: results from a randomized, placebo‐controlled, phase III clinical trial (BREEZE‐AD4). (1st September 2022)

Authors:
Bieber, Thomas; Reich, Kristian; Paul, Carle; Tsunemi, Yuichiro; Augustin, Matthias; Lacour, Jean‐Philippe; Ghislain, Pierre‐Dominique; Dutronc, Yves; Liao, Ran; Yang, Fan E.; Brinker, Dennis; DeLozier, Amy M.; Meskimen, Eric; Janes, Jonathan M.; Eyerich, Kilian
Journal:
British journal of dermatology
Issue:
Volume 187:Number 3(2022)
Page Start:
338
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Efficacy and safety of baricitinib in combination with topical corticosteroids in patients with moderate‐to‐severe atopic dermatitis with inadequate response, intolerance or contraindication to ciclosporin: results from a randomized, placebo‐controlled, phase III clinical trial (BREEZE‐AD4). (20th July 2022)

Authors:
Bieber, Thomas; Reich, Kristian; Paul, Carle; Tsunemi, Yuichiro; Augustin, Matthias; Lacour, Jean‐Philippe; Ghislain, Pierre‐Dominique; Dutronc, Yves; Liao, Ran; Yang, Fan E.; Brinker, Dennis; DeLozier, Amy M.; Meskimen, Eric; Janes, Jonathan M.; Eyerich, Kilian
Journal:
British journal of dermatology
Issue:
Volume 187:Number 3(2022)
Page Start:
338
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation: an exploratory, randomised, placebo-controlled trial. Issue 4 (April 2022)

Authors:
Ely, E Wesley; Ramanan, Athimalaipet V; Kartman, Cynthia E; de Bono, Stephanie; Liao, Ran; Piruzeli, Maria Lucia B; Goldman, Jason D; Saraiva, José Francisco Kerr; Chakladar, Sujatro; Marconi, Vincent C; Alatorre-Alexander, Jorge; Altclas, Javier David; Casas, Marcelo; CevoliRecio, Valeria; Eller...
Journal:
Lancet
Issue:
Volume 10:Issue 4(2022)
Page Start:
327
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Evaluation of hepatitis B virus in clinical trials of baricitinib in rheumatoid arthritis. Issue 1 (25th February 2020)

Authors:
Harigai, Masayoshi; Winthrop, Kevin; Takeuchi, Tsutomu; Hsieh, Tsu-Yi; Chen, Yi-Ming; Smolen, Josef S; Burmester, Gerd; Walls, Chad; Wu, Wen-Shuo; Dickson, Christina; Liao, Ran; Genovese, Mark C
Journal:
RMD open
Issue:
Volume 6:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗